Mitochondrial tRNA-derived small RNAs in metabolic disease: from biogenesis to clinical translation
Mitochondrial tRNA-derived small RNAs (mt-tsRNAs), exemplified by mt-tRF-LeuTAA, have emerged as tissue-specific regulators of mitochondrial metabolism and glucose homeostasis. In pancreatic β-cells, mt-tRF-LeuTAA sustains oxidative phosphorylation to support glucose-stimulated insulin secretion; conversely, its downregulation in skeletal muscle enhances insulin sensitivity, indicating bidirectional metabolic control. A more provocative but mechanistically unresolved proposal is that sperm-borne mt-tsRNAs transmit paternal metabolic information across generations. Circulating mt-tsRNAs are also gaining attention as minimally invasive biomarkers, although direct clinical validation remains limited, and their dynamics in early-stage type 2 diabetes and non-alcoholic fatty liver disease are largely unexplored. Their clinical translation is further hindered by the fact that stress-induced cleavage enzymes remain unidentified, detection platforms lack standardized quantification protocols that would ensure cross-study reproducibility, and the electrostatic barrier of the inner mitochondrial membrane poses a substantial obstacle to therapeutic targeting. At present, mt-tsRNAs are best characterized as promising research tools whose value as liquid biopsy biomarkers will depend on rigorous validation in large-scale prospective cohorts with harmonized assay standards.
Authors
- 吴立培
- 宣世海
- Jing Lü (ORCID: https://orcid.org/0000-0002-1684-9258)
- Hui Sun (ORCID: https://orcid.org/0000-0002-6492-3459)
- Honghong Li
Institutions
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fendo.2026.1986192
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00